Satellite Symposium
Home > Scientific Program > Satellite Symposium 
Breakfast |
Halla Hall |
Session Topic |
|
|
Exploring the latest pathway to treat dyslipidemia in stroke patients Woo-Keun Seo (Korea University Guro Hospital, Korea) | |||
|
The benefit of Losartan + CCB for hypertension treatment Yong-Jin Cho (Ilsan Paik Hospital, Korea) |
|||
Lotus Hall |
Post stroke Management: Complications and Co-morbid Conditions |
|
|
|
Post Stroke Pain Management Jong S. Kim (Asan Medical Center, Korea) | |||
|
Lipid Management for Stroke Patients Jaseong Koo (Seoul St.Mary's Hospital, Korea) |
|||
Luncheon |
Halla Hall |
Rivaroxaban, a novel anticoagulant for stroke patients with atrial fibrillation |
|
|
Stroke and Atrial fibrillation; What is the challenge in Korea? Jong-Moo Park (Eulji General Hospital, Korea) |
|||
|
Optimal anticoagulation with rivaroxaban; What do ROCKET AF tell us? John Vincent Amerena (University of Melbourne, VIC Australia) |
Lotus Hall |
Session Topic |
|
|
Vascular contribution to late-life dementia Jae Hong Lee (Asan Medical Center, Korea) |
|||
Evening |
Halla Hall |
Session Topic |
|
|
Triflusal and unmet needs in antithrombotics for stroke prevention Oh-Young Bang (Samsung Medical Center, Korea) |
|||
Lotus Hall |
Statin and Atherosclerosis: an emerging target for CV risk reduction |
|
|
|
From the past and promises for the future for carotid intima-media thickness Michiel L Bots (University Medical Center Utrecht, The Netherlands) |
|||
|
Statin and Atherosclerosis: an emerging target for CV risk reduction Seung-Hoon Lee (Seoul National University Hospital, Korea) |
Breakfast |
Halla Hall |
Polyvascular disease & PLAVIX |
|
|
Risks, Outcome and Clinical implication of Polyvascular disease in Stroke Jae Kwan Cha (Dong-A University Medical Center, Korea) |
|||
Lotus Hall |
Update of anti-thrombotic therapy : Consider ethnic difference |
|
|
|
Antithromobotic therapy in asian patients with ischemic cerebrovascular disease Kyung-Yul Lee (Gangnam Severance Hospital, Korea) |
|||
|
East asian paradox: Paradigm shift to ethnicity-based antithrombotic therapy Young-Hoon Jeong (Gyeongsang National University Hospital, Korea) |
|||
Luncheon |
Halla Hall |
Session Topic |
|
|
Where are we now? An overview of the current landscape for stroke prevention in AF Dong-Wha Kang (Asan Medical Center, Korea) |
|||
|
Efficacy and Safety of Dabigatran in Asian population with Atrial Fibrillation Jyh-Hong Chen (National Cheng Kung University Hospital, Taiwan) |
|||
Lotus Hall |
VCI Researches in Korea |
|
|
|
Epidemiology of VCI Soo-Jin Cho (Hallym University College of Medicine, Korea) |
|||
|
Dx & Mx of VCI-Review of new guidelines Soo-Joo Lee (Eulji University Hospital, Korea) |
|||
|
Glitter Study Hee-Joon Bae (Seoul National University Bundang Hospital. Korea) |
